Suchergebnisse - "De Cruz, Peter"

PubPharm (4)

1

Transitioning patients from intravenous to subcutaneous infliximab and vedolizumab for inflammatory bowel disease : what is the opportunity cost of improving access to healthcare?

enthalten in: Internal medicine journal | 2024

von Hilley, P. | Wong, D. | Ma, R. | +2

2

Outcomes out to 12 months after sequential use of high-dose tofacitinib following infliximab in acute severe ulcerative colitis

enthalten in: Internal medicine journal | 2023

von Eqbal, A. | Hilley, P. | Choy, M. | +2

3

Examination of the relationship between disease activity and patient-reported outcome measures in an inflammatory bowel disease cohort

enthalten in: Internal medicine journal | 2018

von Jackson, B. | Con, D. | Gorelik, A. | +3

4

Design considerations for an eHealth decision support tool in inflammatory bowel disease self-management

enthalten in: Internal medicine journal | 2018

von Jackson, B. | Con, D. | De Cruz, P.

1
[1]